Glazer Capital, LLC 13D and 13G filings for Y-mAbs Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-13 4:52 pm Sale | 2025-09-30 | 13G | Y-MABS THERAPEUTICS INC YMAB | Glazer Capital, LLC | 0 0.000% | -2,654,700 (Position Closed) | Filing |
| 2025-08-15 4:28 pm Purchase | 2025-08-08 | 13G | Y-MABS THERAPEUTICS INC YMAB | Glazer Capital, LLC | 2,654,700 5.840% | 2,654,700 (New Position) | Filing |